PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer
about
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisRNA interference of pax2 inhibits growth of transplanted human endometrial cancer cells in nude mice.Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease.Antimicrobial peptides and gut microbiota in homeostasis and pathology.Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?Human beta-defensin-1 suppresses tumor migration and invasion and is an independent predictor for survival of oral squamous cell carcinoma patientsAlzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune SystemSignaling pathways of PAX2 and its role in renal interstitial fibrosis and glomerulosclerosis.An intron 9 containing splice variant of PAX2.Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease.Less expression of prohibitin is associated with increased paired box 2 (PAX2) in renal interstitial fibrosis rats.A role of human beta defensin-1 in predicting prostatic adenocarcinoma in cases of false-negative biopsy.Association between graves' disease and renal coloboma syndrome: a case report.Beta defensin-1 gene polymorphisms and susceptibility to atypical squamous cells of undetermined significance lesions in Italian gynecological patients.Human β-defensins and psoriasin/S100A7 expression in salivary glands: anti-oncogenic molecules for potential therapeutic approaches.Paired box 2 promotes progression of endometrial cancer via regulating cell cycle pathway
P2860
Q28069422-7A5498AD-410C-49F8-B024-F164BD0663D9Q33579715-51DD4445-E21E-4F3D-9E4B-A15FFE157C22Q33982997-4D48B0A5-1FD1-4B13-A544-26AC575C8271Q34987870-BAE0235F-4FA3-4E0B-8377-0B561ED69051Q35010044-6C69BA31-AB59-4AAF-9185-E6C60192FC7FQ35128306-326B48DD-C1ED-4AF7-B488-2CEEDDE6DFD2Q35664117-F7C118F8-E961-4699-8F84-59BFDDE014BFQ38058558-C02F0CBF-7C8C-48D8-9235-F52D3E2B9ADFQ39847482-7EBD9C85-8AC9-49DF-AD42-239F8F209505Q40287878-2BDD8D9C-055F-4FB7-9D34-11C59B4208E1Q41905590-8AA0B3E1-D5FD-438C-8D8E-34E0CAE17CBFQ42514699-4AC02E64-7B39-41FF-B929-E7E67F3F12A3Q42561687-9776F83B-A997-41CB-B90B-096494F16C05Q44248326-0654C585-6E96-4807-B627-AC6C98B738E1Q54335180-C84E1555-5CA1-4A9F-B2FB-F5852670F18FQ58551515-649D2A0B-0E61-4EC8-82ED-48395C3F08EF
P2860
PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@ast
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@en
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@en-gb
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@nl
type
label
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@ast
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@en
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@en-gb
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@nl
prefLabel
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@ast
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@en
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@en-gb
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@nl
P2093
P2860
P3181
P1433
P1476
PAX2 oncogene negatively regul ...... defensin-1 in prostate cancer
@en
P2093
Carlton D Donald
Rebecca S Bullard
Sudeep K Bose
Willietta Gibson
P2860
P304
P3181
P356
10.1016/J.MOLIMM.2008.11.004
P407
P577
2009-03-01T00:00:00Z